Dystonia 3×3: A Training Guideline for Beginners in Botulinum Neurotoxin Treatment of Cervical Dystonia
Open Access
Abstract
Cervical dystonia (CD) is a hyperkinetic movement disorder characterized by involuntary muscle contractions leading to abnormal postures of the head and neck. The injection of botulinum neurotoxin type A (BoNT-A) into the muscles involved is the treatment of choice for CD. BoNT-A therapy of CD requires appropriate training, which has not been standardized in Germany. To address the key challenges in BoNT-A education, an expert panel developed a simplified step-by-step treatment guideline for beginners, adapted from the established Col-Cap-Concept (“Dystonia 3×3”). Based on expert consensus, recommendations were developed for the core clinical elements of BoNT-A treatment in CD—recognition of the movement pattern, identification of target muscles, development of an injection plan, ultrasound-guided injection, and dosing, taking into account the target audience of the guideline. As such, Dystonia 3×3 provides a user-friendly beginner’s guidebook, enhancing accessibility and standardization of CD treatment training. Further research is required to evaluate its clinical efficacy and suitability for training.Keywords
Funding Information
- Ipsen Pharma GmbH
This publication has 33 references indexed in Scilit:
- Computer Vision Technologies in Movement Disorders: A Systematic ReviewMovement Disorders Clinical Practice, 2025
- Isolated Cervical Dystonia: Diagnosis and ClassificationMovement Disorders, 2023
- Current Guidelines for Classifying and Diagnosing Cervical Dystonia: Empirical Evidence and RecommendationsMovement Disorders Clinical Practice, 2021
- Dysphagia in cervical dystonia patients receiving optimised botulinum toxin therapy: a single-center retrospective cohort studyJournal of Neural Transmission, 2020
- Frequency of different subtypes of cervical dystonia: a prospective multicenter study according to Col–Cap conceptJournal of Neural Transmission, 2019
- How satisfied are cervical dystonia patients after 3 years of botulinum toxin type A treatment? Results from a prospective, long-term observational studyJournal of Neurology, 2019
- A simplified ultrasonography-guided approach for neurotoxin injection into the obliquus capitis inferior muscle in spasmodic torticollisJournal of Neural Transmission, 2018
- Botulinum toxin treatment failures in cervical dystonia: causes, management, and outcomesJournal of Neurology, 2016
- Selection of Muscles for Botulinum Toxin Injections in Cervical DystoniaMovement Disorders Clinical Practice, 2015
- Practical guidance for CD management involving treatment of botulinum toxin: a consensus statementJournal of Neurology, 2015